Prognostic Enrichment Design in Clinical Trials for Autosomal Dominant Polycystic Kidney Disease: The TEMPO 3:4 Clinical Trial.

Prognostic Enrichment Design in Clinical Trials for Autosomal Dominant Polycystic Kidney Disease: The TEMPO 3:4 Clinical Trial. — المؤلف: Irazabal, Maria V — Kidney international reports Nov 2016

المؤلف
Irazabal, Maria V
النشر
Kidney international reports Nov 2016
الوصف
213-220 p.